Planning and Analyzing Adaptive Group Sequential Survival Trials
From MaRDI portal
Recommendations
- Group-sequential response-adaptive designs for censored survival outcomes
- On adaptive extensions of group sequential trials for clinical investigations
- Planning the duration of a survival group sequential trial with a fixed follow-up time for all subjects
- Robust group sequential designs for trials with survival endpoints and delayed response
- Group sequential and confirmatory adaptive designs in clinical trials
- An Adaptive Approach to Implementing Bivariate Group Sequential Clinical Trial Designs
- Group sequential tests for long-term survival comparisons
- Sequential Analysis of Survival Times in Clinical Trials
Cited in
(26)- Sequential tests for non-proportional hazards data
- Adaptive designs for the one-sample log-rank test
- Data-Driven Analysis Strategies for Proportion Studies in Adaptive Group Sequential Test Designs
- Interim design modifications in time-to-event studies
- Information fraction estimation based on the number of events within the standard treatment regimen
- A useful design utilizing the information fraction in a group sequential clinical trial with censored survival data
- Planning the duration of a survival group sequential trial with a fixed follow-up time for all subjects
- Quantifying treatment differences in confirmatory trials under non-proportional hazards
- Adaptive enrichment designs with a continuous biomarker
- Sample size optimization and initial allocation of the significance levels in group sequential trials with multiple endpoints
- Confirmatory adaptive group sequential designs for single‐arm phase II studies with multiple time‐to‐event endpoints
- Two-stage randomized clinical trials with a right-censored endpoint: comparison of frequentist and Bayesian adaptive designs
- A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation
- Seamless phase 2/3 oncology trial design with flexible sample size determination
- Point estimation for adaptive trial designs. I: A methodological review
- Confirmatory adaptive designs for clinical trials with multiple time-to-event outcomes in multi-state Markov models
- Adaptive seamless designs with interim treatment selection: a case study in oncology
- Adaptive weight selection for time-to-event data under non-proportional hazards
- Methods of designing two-stage winner trials with survival outcomes
- Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls
- Adjusted inference for multiple testing procedure in group-sequential designs
- Nonparametric adaptive enrichment designs using categorical surrogate data
- Point and interval estimation in two-stage adaptive designs with time to event data and biomarker-driven subpopulation selection
- Blinded-into-unblinded interim analyses for clinical trials with time-to-event endpoints
- Adaptive designs with arbitrary dependence structure based on Fisher's combination test
- A random walk approach for quantifying uncertainty in group sequential survival trials
This page was built for publication: Planning and Analyzing Adaptive Group Sequential Survival Trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5122866)
